Description

Erius Syrup 0.5 mg/ml. 60 ml. Vial №1

Ingredients

Erius syrup contains desloratadine as the active ingredient. It also includes inactive ingredients such as propylene glycol, sorbitol, citric acid, sodium benzoate, and purified water.

Dosage

The recommended dosage for Erius syrup is 2.5 ml (1.25 mg) once daily for adults and children over 12 years of age. For children aged 6 to 11 years, the recommended dosage is 1.25 ml (0.625 mg) once daily.

Indications

Erius syrup is indicated for the relief of symptoms associated with allergic rhinitis (hay fever) and chronic idiopathic urticaria (hives) in adults and children.

Contraindications

Do not use Erius syrup if you are allergic to desloratadine or any of the inactive ingredients. It is not recommended for children under 6 years of age.

Directions

Shake the bottle well before each use. Use the provided measuring device to ensure the correct dosage. Take Erius syrup orally with or without food.

Scientific Evidence

Desloratadine, the active ingredient in Erius syrup, is a second-generation antihistamine that exhibits selective peripheral H1-antagonist activity. Studies have shown that desloratadine is effective in relieving symptoms of allergic rhinitis and chronic idiopathic urticaria with minimal sedative effects compared to first-generation antihistamines.

Additional Information

Erius syrup provides 24-hour relief from allergy symptoms, such as sneezing, runny nose, and itching. It is well-tolerated and has a low risk of causing drowsiness. However, individuals should avoid driving or operating heavy machinery until they know how the medication affects them.

Further research and clinical trials have demonstrated the safety and efficacy of desloratadine in the treatment of allergic conditions. Desloratadine has been shown to have a rapid onset of action, providing quick relief from symptoms. It is considered a first-line treatment option for allergic rhinitis and chronic urticaria due to its effectiveness and favorable side effect profile.

Comparative studies have shown that desloratadine has similar efficacy to other second-generation antihistamines such as loratadine and cetirizine but with a lower incidence of sedation. This makes Erius syrup a preferred choice for individuals seeking relief from allergy symptoms without experiencing drowsiness.